Category:Mark M. Davis of Atherton CA (US)

Mark M. Davis of Atherton CA (US)

Executive Summary

Mark M. Davis of Atherton CA (US) is an inventor who has filed 3 patents. Their primary areas of innovation include SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS (2 patents), the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit (1 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), and they have worked with companies such as The Board of Trustees of the Leland Stanford Junior University (3 patents). Their most frequent collaborators include (2 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• A61P37/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 2 patents
• A61K47/6937 (the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit): 1 patents
• A61K31/437 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
• A61P35/00 (Antineoplastic agents): 1 patents
• B82Y5/00 (Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery): 1 patents
• C07K14/79 (PEPTIDES (peptides in foodstuffs): 1 patents
• C07K14/70539 (PEPTIDES (peptides in foodstuffs): 1 patents
• C12N9/1085 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• G01N33/56972 (for microorganisms, e.g. protozoa, bacteria, viruses): 1 patents
• C07K2319/90 (PEPTIDES (peptides in foodstuffs): 1 patents
• C12Y205/01078 (ENZYMES): 1 patents
• A61K39/39 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K39/215 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K2039/54 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K2039/543 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K2039/55511 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents

Companies

Error creating thumbnail: File missing

List of Companies

• The Board of Trustees of the Leland Stanford Junior University: 3 patents

Collaborators

• Qian Yin of Los Altos CA (US) (2 collaborations)
• Venkata Vamsee Aditya Mallajosyula of Palo Alto CA (US) (1 collaborations)
• Wei Luo of Redwood City CA (US) (1 collaborations)
• Bali Pulendran of Redwood City CA (US) (1 collaborations)